On Nov 05, 2025, PEN reported earnings of 0.97 USD per share (EPS) for Q3 25, beating the estimate of 0.93 USD, resulting in a 4.22% surprise. Revenue reached 354.69 million, compared to an expected 344.20 million, with a 3.05% difference. The market reacted with a +17.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analysts forecast an EPS of 1.10 USD, with revenue projected to reach 365.62 million USD, implying an increase of 13.40% EPS, and increase of 3.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
What were Penumbra, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Penumbra, Inc. reported EPS of $0.97, beating estimates by 4.22%, and revenue of $354.69M, 3.05% above expectations.
How did the market react to Penumbra, Inc.'s Q3 2025 earnings?
The stock price moved up 17.32%, changed from $225.54 before the earnings release to $264.61 the day after.
When is Penumbra, Inc. expected to report next?
The next earning report is scheduled for Feb 16, 2026.
What are the forecasts for Penumbra, Inc.'s next earnings report?
Based on 21
analysts, Penumbra, Inc. is expected to report EPS of $1.10 and revenue of $365.62M for Q4 2025.